Inclusion Criteria:  Men or women ≥18 years old Patients affected by age-related cataract <3 according to the Lens Opacities Classification System III scale (LOCS III) Meibomian gland dysfunction (MGD) diagnosed using slit lamp examination, following the criteria reported in the paper Arita R. et al, Am J Ophthalmol. 2016 Sep;169:125-137. Fluorescein tear BUT <7 seconds  Exclusion Criteria:  Subjects with documented history and / or clinical signs of concomitant presence of an eye infection caused by viruses such as herpes simplex virus (HSV) or fungi in the previous 3 months. Patients with anterior blepharitis or Demodex Meibomian gland atrophy score greater than 2/3 Subject treated with drugs that can have effects on MGD prior to inclusion in the study Active ocular inflammation or history of chronic eye inflammation recurrent in the previous 3 months (e.g. retinitis, macular inflammation, choroiditis, uveitis, iritis, scleritis, episcleritis, keratitis) Eyelid abnormalities affecting eyelid function (entropion, ectropion, neoplasia, blepharospasm, lagophthalmos, severe trichiasis, severe ptosis) Abnormalities of the ocular surface that compromise the integrity of the cornea (e.g.  previous chemical burn, recurrent corneal erosion, corneal epithelial defect, corneal dystrophy)  Subjects who underwent eye surgery in the previous 3 months, including intraocular, oculo-plastic, corneal or refractive surgery Patients suffering from diabetes mellitus, rheumatism, immune diseases and other serious systemic diseases Pregnant or lactating women